detectable in mice injected with S3-SCSM. Tcs were found in such mice and some of the properties of these cells are described below.
Materials and Methods
Mice. CAF~ female mice, 8-12 wk old, were used for all experiments. They were obtained from The Jackson Laboratories, Bar Harbor, ME. BALB.B mice were raised in our breeding colonies at the University of Missouri.
Preparation of S3-SC. $3 was coupled to normal CAF~ or BALB.B spleen cells with chromic chloride as previously described (6) . Mock SC were treated with chromic chloride alone. S3-SCSM, prepared by freeze-thawing S3-SC four times followed by centrifugation at 10,000 g to remove debris (8) , was used for all experiments. Mock SCSM was prepared in the same way using mock SC.
Induction and Assay to Ts. Mice were injected intraperitoneally with 100 mg/kg Cy (Cytoxan; Mead Johnson & Co, Indianapolis, IN) and 2 d later were given mock SCSM or S3-SCSM (amount equivalent to 5 × 107 SC). 8 d later, 5 × 106 spleen cells from these donor mice were transferred intravenously to syngeneic recipients which were immunized 4-6 h later with 0.6 #g $3 (10) . In one experiment, S3-specific Ts were induced by injecting mice intravenously with S3-SCSM. 5 d later spleen cells from these mice were cultured in vitro for 48 h with mock SCSM (controls) or $3 plus S3-SCSM as previously described in detail (8) . 5 x 106 control or Ts cells were transferred intravenously to syngeneic recipients which were immunized the following day with 0.6/~g $3 (8, 9) . S3-specific plaque-forming cells (PFC) were enumerated 5 d later in all experiments (8) . Previous studies have shown that S3-specific Ts induced by the two methods described above belong to different T cell subsets (9) .
Induction and Assay of Tcs. Mice were injected intravenously with S3-SCSM (amount equivalent to 5 × 10"SC). 8 d later spleen cells from these mice were separated on plates coated with the lectin Vicia villosa (V.v.) (E. Y. Laboratories, San Mateo, CA) as described in detail below. Cells which adhered to V.v were mixed with either of the Ts populations described above just before intravenous injection (5 x 106 V.v.-adherent cells and 5 × 10 ~ Ts). In some experiments, V.v.-adherent cells were treated with various antisera and complement (C) before transfer (see below). Other cell populations that were tested for Tcs activity in some experiments included V.v.-nonadherent cells from mice given S3-SC 8 d previously or V.v.-adherent cells from mice given mock SCSM or Cy plus S3-SCSM 8 d previously.
Separation of Spleen Cells on V.v. Plates. Spleen cells were separated on V.v. essentially as described by Iverson et al. (13) . Briefly, V.v. diluted to 500 ~g/ml in saline citrate buffer, pH 5.5, was added to 100-mm tissue culture grade petri plates (Falcon 3003; Falcon Labware, Oxnard, CA) for 45-60 min at room temperature. The V.v. solution was removed, plates were washed twice in pH 7.2 phosphate-buffered saline, and balanced salt solution (BSS) containing 2-3 % fetal calf serum (FCS) was then added for 10-15 min. Spleen cells (10 x 106/ml in BSS/FCS were then added (6-7 ml/plate) and plates were incubated at 37 °C for 45 min. Cells nonadherent to the plates were removed after gentle swirling of the plates and plates were rinsed one or twice in BSS. Cells adherent to the plates were eluted by adding 5 ml BSS containing 1 mg/ml N-acetyI-D-galactosamine (Sigma Chemical Co., St. Louis, MO) and incubating the plates 5-10 min at 37°C. Adherent cells were then removed by vigorous pipetting. Cells were washed once in BSS and counted. Generally, 50-60% of the spleen cells were recovered as nonadherent cells and 15-25% as adherent cells.
Antiserum Treatment. For some experiments, V.v.-adherent spleen cells were treated with anti-Thy-l.2, anti-Lyt-2.2, anti-Lyt-l.2, or anti-I-J b and C before use. The preparation, activity, and specificity of the anti-Lyt antisera were described previously (14) . AntiThy-l.2 was ascites from mice injected with the anti-Thy-l.2 hydridoma HO 13.4, obtained from Dr. Michael Misfeldt, University of Missouri. The monoclonal anti-I-J b reagents WF9.40.5 and WF9.1.4 were kindly supplied by Dr. Carl Waltenbaugh, Northwestern University, Chicago, IL. WF9.1.4 is cytotoxic for Tcs cells in the sheep erythrocyte (SE) system while WF9.40.5 is cytotoxic for Ts but not for Tcs (D. R. Green, personal communication). The culture supernatants containing these monoclonals were used at a final concentration of 1:50. Cells were treated with antiserum and low toxicity rabbit complement by a two-step cytotoxicity procedure (14) .
PFC Assay. IgM PFC were enumerated as previously described (8) using $3 coupled to sheep erythrocytes (S3-SE) as indicator cells (15) . Results are presented as PFC/spleen but the conclusions would not differ if results were expressed as PFC/106 spleen cells.
Results

Mice Injected with S3-SCSM Have Cells that
Interfere with Ts Activity. Previous studies (10) from this laboratory have shown that S3-specific Ts could be induced by S3-SCSM in Cy-treated mice but not in normal mice (10) . Similarly, the data shown in groups A-C of Table I illustrate that spleen cells from Cy-treated mice injected with S3-SCSM (group B) are able to suppress the IgM PFC response to $3 whereas cells from mice given S3-SCSM but no Cy (group C) have no detectable suppressor activity. The suppressor cells induced in Cy-treated mice with S3-SCSM have been previously described and are S3-specific Lyt-l-2 ÷, I-J + T cells (9, 10) . The necessity to treat mice with Cy to obtain detectable Ts suggested that a Cy-sensitive cell which could interfere with the activation or expression of Ts in this system might be present in normal mice given S3-SCSM. Cells with the ability to interfere with Ts function, i.e., Tcs, have been shown by others to be adherent to V.v. (13, 16) . If spleen cells from normal mice injected with S3-SCSM do contain Tcs, V.v.-adherent cells from those mice should be able to abrogate the function of the Ts induced in Cy-treated mice. To investigate this possibility, spleen cells from normal mice given S3-SCSM 8 d previously were separated on V.v. plates and the V.v.-adherent and -nonadherent cells or unseparated cells from these mice were mixed with an equal number of Ts induced in Cy-treated mice. The ability of these Ts to suppress the response to $3 (group B in Table I) Table  I (Table II) . As before, the V.v.-adherent cells from mice injected with S3-SCSM almost completely abrogated the ability of the Ts to suppress the $3 response (group D vs. group B). By contrast, V.v.-adherent cells from normal mice (group E) or from mice injected with PVP-SCSM (group F) had no effect on Ts activity. Thus cells with the ability to interfere with S3-specific Ts are apparently induced by S3-SCSM.
Contrasupressor Cells Are Not Present in Cy-treated Mice Given S3-SCSM.
We previously suggested (10) that the ability to induce S3-specific Ts with S3-SCSM in Cy-treated mice but not in normal mice was due to the fact that cells which interfered with Ts activity were eliminated by Cy, thus allowing Ts activity to be expressed. To directly test this possibility, spleen cells from both normal and Cytreated mice given S3-SCSM 8 d previously were separated on V.v. and the V.v.-adherent cells were mixed with an equal number of unfractionated spleen cells Table I from Cy-treated mice given S3-SCSM (Ts control) ( Table III) . As in the previous experiments, V.v.-adherent cells from mice given S3-SCSM and no Cy (group D) abrogated the ability of Ts to suppress the $3 response. By contrast, V.v.-adherent cells from mice given the same S3-SCSM and Cy (group E) were unable to interfere with Ts activity, suggesting that cells with contrasuppressor activity are Cy sensitive.
Removal of Contrasuppressor Cells Reveals Ts Activity in Cells from Mice Injected with S3-SCSM.
Having established that mice injected with S3-SCSM have cells which can interfere with the activity of Ts induced by S3-SCSM in Cy-treated mice, it was of interest to determine whether the contrasuppressor cells prevented the activation of Ts or merely prevented their expression. To begin to assess this question, we asked whether the removal of contrasuppressor cells from a spleen cell population would enable the remaining cells to suppress the $3 response. Therefore mice were injected with S3-SCSM or with mock SCSM as a control. 8 d later spleen cells from the mice given S3-SCSM were separated on V.v. and the various unseparated or separated cell populations were injected into mice that were then immunized with $3. The results of two experiments of this type are shown in Table IV . As shown previously (see above), unfractionated spleen Table  IV ), these V.v.-nonadherent cells suppressed the response as effectively as did spleen cells from Cy-treated mice injected with S3-SCSM (group E), although in the majority of experiments the Ts induced in Cy-treated mice were more effective (e.g., Exp. 1 in Table IV ). These results suggest that contrasuppressor cells in mice injected with S3-SCSM act by preventing the expression of Ts activity rather than by preventing the activation of Ts. The fact that both suppressor and contrasuppressor cells are present in spleen cells from mice given S3-SCSM also explains the inability of unfractionated spleen cells from these mice to abrogate the activity of Ts induced in Cy-treated mice ( (Tables  I and II) , it was important to determine if these cells might be similar to the Tcs described by others (16) . Therefore spleen cells from mice injected 8 d earlier with S3-SCSM were separated on V.v. plates. The V.v.-adherent cells were then treated with anti-Thy-l.2, anti-Lyt-l.2, anti-Lyt-2.2 and C, or with C alone before transfer with Ts to recipient mice (Table V) Table IV. cells to abrogate Ts activity, indicating that the contrasuppressor cells are Lyt-1 + T cells. Treatment with anti-Lyt-2.2 and C (group G) had a variable effect in these as well as several other experiments. In general, contrasuppressor activity was only partially eliminated by anti-Lyt-2.2 so that it was not possible to draw any definite conclusion concerning the presence or absence of Lyt-2 on these cells. It should be noted that the same anti-Lyt-2.2 serum used here does abrogate the activity of two different subsets of S3-specific Ts (9, 10) so that the results in Table V cannot be due to the inactivity of the antiserum used. It has been shown that the Tcs described by Green et al. (16, 21) have I-J determinants that are recognized by some monoclonal anti-I-J b reagents (e.g., WF9. (Table VI) . As noted above with CAF~ mice, spleen cells from BALB.B mice given Cy and S3-SCSM suppressed the $3 response in recipient mice (group B vs. group A) while cells from mice given S3-SCSM and no Cy had no effect on the $3 response (group C). V.v.-adherent cells from these mice abrogated the activity of the Ts (group D). Treatment of the V.v.-adherent Tcs cells with the monoclonal WF9.40.5 had little effect on Tcs activity (group E) while the other monoclonal (WF9.1.4) almost completely eliminated the ability of these cells to abrogate Ts activity (group E vs. group B). Thus, Tcs induced by S3-SCSM apparently bear I-J determinants that are defined by the same monoclonal anti-I-J b reagent that eliminates Tcs in the SE system.
Contrasuppressor Cells Do Not Abrogate the Activity of S3-spec~c Ts Induced In Vitro.
The results presented above demonstrate that Tcs induced by S3-SCSM can abrogate the activity of S3-specific Ts induced in Cy-treated mice. We have also described and characterized (8, 9) a subset of S3-specific Ts that are induced by culturing spleen cells from mice injected with S3-SCSM in vitro with $3 and S3-SCSM. These in vitro induced Ts belong to a separate T cell subset from the Ts induced in Cy-treated mice (9) and previous studies had indirectly suggested that the activity of these Ts could be neutralized by Lyt-1 + T cells present in the same spleen cell populations (8) . . Cells were then transferred to normal CAF1 mice that were immunized on the following day with $3; PFC were determined 5 d later (Table VII) . Clearly, V.v.-adherent cells had no effect on the ability of the in vitro induced Ts to suppress the $3 response (group B vs. group C). Because a 24-h interval between cell transfer and immunization of recipients is required to demonstrate optimal suppression with the in vitro induced Ts, it was important to determine whether the lack of effect of Tcs was due to a real difference in the ability of Tcs to abrogate the activity of different subsets of Ts or whether Tcs activity could not be demonstrated at all when the interval between cell transfer and immunization was 24 h rather than the 4-6 h used in all of the previous experiments. Thus, mice were also injected with Cy and mock SCSM (control) or with Cy and S3-SCSM (Ts). Ts induced either by this latter method or Ts induced in vitro were then mixed with the same population of V.v.-adherent spleen cells from mice given S3-SCSM 8 d previously and all recipients were immunized 24 h after cell transfer (Table VII, Exp. 2). The V.v.-adherent spleen cells had no effect on the ability of the in vitro induced Ts to suppress the $3 response (group C vs. group B), while the suppressive activity of the Ts induced in Cy-treated mice was largely abrogated by the same cell population. Thus Tcs appear to have different effects on different subsets of Ts.
Discussion
The studies described here have established that normal mice injected with S3-SCSM have in their spleens two types of regulatory T cells, Ts (Table IV) and a second T cell which is adherent to V.v. and which acts to abrogate or contrasuppress the activity of S3-specific Ts (Table I ). Because these two T cell populations are both induced by S3-SCSM, unfractionated spleen cells from mice injected with S3-SCSM have little, if any, ability to suppress the antibody response to $3 (Table I, group C) or to contrasuppress the activity of Ts induced in Cytreated mice (Table I , group E). By contrast, separation of the spleen cells on V.v. reveals suppressor activity in the V.v.-nonadherent cells (Table IV) and contrasuppressor activity in the V.v.-adherent cells (Table I , group G). The finding that S3-SCSM activates Tcs in addition to Ts in normal mice provides an explanation for our inability to detect Ts in such spleens in these as well as previous studies (8) (9) (10) . As shown previously, S3-specific Ts are readily detected when donor mice are given Cy before the injection of S3-SCSM (10 and Table  I , group B). We previously hypothesized (10) that Cy acted by eliminating cells which interfered with Ts activity. Direct evidence for that hypothesis was obtained in the present studies since V.v.-adherent cells from Cy-treated mice given S3-SCSM were unable to abrogate Ts activity, whereas the same cell population obtained from mice not given Cy did abrogate Ts activity (Table III) . The finding that cells with contrasuppressor activity are Cy sensitive is consistent with the results of a recent study which showed that a Cy-sensitive T cell can abolish the activity of a Cy-resistant subset of Ts. Both of these cells were induced by injection of trinitrophenyl (TNP)-SC into the anterior chamber of the eye (17, 18) . Moreover, a serum factor with antisuppressor activity has been recently described and this factor was not produced by Cy-treated mice (19) .
Gershon et al. (12) first showed that T cells with contrasuppressor activity can regulate the in vitro antibody response to SE. They defined a Tcs circuit in which Lyt-2 + T cells (contrasuppressor inducers) acted on Lyt-l+2 + transducer cells which in turn activated Lyt-l+2 -contrasuppressor effector cells (12, 16, 20) . In their system (16), contrasuppressor effector cells were shown to act on helper T cells (Th) to render them resistant to Ts signals. The contrasuppressor cell we describe here has also been shown to be a T cell and to be Lyt-1 + (Table  V) . Whether the Tcs described here is a Lyt-l+2 -contrasuppressor effector cell or a Lyt-I +2 + T cell perhaps similar to the contrasuppressor transducer cell (12, 16, 20) is not known, since treatment with anti-Lyt-2 and C partially but never completely eliminated contrasuppressor activity (Table V) . The Tcs described here also were found to bear I-J determinants (Table VI) similar or identical to the I-J determinants found on Tcs that regulate responses to SE (D. R. Green, personal communication), which suggests their similarity to Tcs described in other systems (12, 20, 21) . However, while the Tcs described here may be similar to those described by Green et al. (16, 21) , it is unlikely that the Tcs in our system act by making Th resistant to Ts signals (16) , since the antibody response to $3 presumably does not involve Th interaction with B cells (22) . The mechanism by which Tcs regulate the $3 response is not known at this time. Two likely possibilities are that Tcs interact directly with Ts and neutralize their activity or that Tcs somehow make S3-specific B cells resistant to Ts signals. Studies are currently in progress to determine which, if either, of those mechanisms are operative in this system. An unexpected observation in these studies was the finding that the Tcs which consistently abrogated the suppression mediated by S3-specific Ts induced in Cy-treated mice injected with S3-SCSM had no effect on S3-specific Ts induced in vitro (Table VII) . Previous studies have established that both of these Ts are $3 specific and are Lyt-l-2 ÷, I-J ÷ T cells, but differ in several other properties, indicating that they are separate subsets of Ts (9) . The Ts induced by S3-SCSM in Cy-treated mice bind to S3-SCSM but not to anti-S3-coated plates (10), appear to directly suppress S3-specific B cells (9) , and are apparently not V, restricted (Braley-Mullen, unpublished results). By contrast, the in vitro induced Ts bind to anti-S3-coated plates (9), require a Cy-sensitive T cell in the recipient to mediate suppression (9) , and are V. restricted (unpublished results). These later Ts are thus similar to the second order Ts (Ts2) described by others (reviewed in 23). Although it has been suggested that all types of Ts may not be regulated by cells in the contrasuppressor circuit (21) , considerable indirect evidence suggests that the in vitro induced Ts are regulated by contrasuppressor cells. For example, our initial studies indicated that suppression mediated by these cells was lost if supraoptimal numbers of T cells were transferred to recipient mice (8) , suggesting that cells which could interfere with Ts were also present in the cultured spleen cell population. In addition, the degree of suppression obtained with low numbers of transferred cells was often, although not always, increased when cells were treated with anti-Lyt-l.2 and C before transfer (9) . Moreover, the need to culture the cells to obtain detectable Ts suggests that at ]east the precursor of the Ts is influenced by contrasuppressor cells, the activity of which might be diminished or lost during culture. The finding that Tcs obtained from mice injected 8 d earlier with S3-SCSM do not affect the activity of the in vitro induced Ts suggests the possibility that, in spite of the indirect evidence discussed above, this Ts subset is not affected by Tcs. Alternatively, it is possible that more than one subset of Tcs exists and that the Tcs detected in mice injected 8 d previously with S3-SCSM do not affect all subsets of Ts. Recent evidence in another system (24) indicates that distinct subsets of Tcs regulate suppression mediated by distinct subsets of Ts, so that this is not an unlikely possibility. It is also posible that only the precursors of the in vitro induced Ts are susceptible to Tcs so that an effect of Tcs might have been observed if the Tcs had been added at the initiation of culture. Studies currently in progress should help to resolve these questions.
The specificity of Tcs in the SE system has been reported (12, 21) to be less stringent than that of Ts or Th in that the activity of a Tcs factor induced by SE could be adsorbed by other types of erythrocytes (12, 21) . Similarly, Rohrer and Kemp (24) have shown that at least one Tcs subset is highly cross-reactive although another is SE specific. Our studies indicate that the Tcs described here are induced by S3-SCSM but not by another TI antigen, PVP-SCSM, and that the Tcs are not present in normal mice (Table II) . The fact that PVP-SCSM does not activate the Tcs which regulate the $3 response suggests that Tcs are not entirely antigen nonspecific, but our data do not exclude the possibility that they could be activated by more closely related antigens such as other pneumococcal polysaccharides.
Finally, it is important to emphasize that the Tcs described here do not by themselves have any discernible effect on the $3 response (Table IV, group D) . This strongly suggests that Tcs are not identical to Ta, which have been shown to interact antagonistically with Ts to regulate the $3 response (3, 11) . Athough Tcs and Ta are both Ly-1 ÷ cells (Table V and reference 11), Ta markedly augments the antibody response to $3 when injected into normal mice (11) whereas Tcs clearly do not have this effect. Thus the antibody response of mice to a so-called TI antigen such as $3 can be influenced by multiple subsets of regulatory T cells that can now be separated both functionally and physically so that their properties and roles in the immune response can be studied in detail. It will be of particular interest to determine if Tcs such as those described here can be activated by free $3. If so, Tcs may prove to be important in enabling polysaccharide antigens such as $3 to elicit a positive immune response, since these types of antigens tend to induce tolerance very effectively. (2, 5, 22) . It has previously (25) been suggested that the activation of T cells which can block Ts activity may be essential if an immune response is to take place. Tcs have also been shown (26) to be capable of interfering with tolerogenic signals in vivo and are important in allowing neonatal cells to exhibit positive immune function (16, 21) . Clearly further studies will be required to fully define the role of Tcs in the regulation of the immune response to $3 as well as other types of antigens. Summary A soluble membrane component of type III pneumococcal polysaccharidecoupled spleen cells (S3-SCSM) induces S3-specific suppressor T cells (Ts) in mice. These Ts can be detected only if mice are pretreated with cyclophosphamide (Cy) or if cells adherent to the lectin Vitia villosa are removed from the spleen cell population prior to transfer. The V. villosa-adherent spleen cells from mice injected with S3-SCSM could abrogate suppression mediated by Ts induced by S3-SCSM in Cy-treated mice. The V. villosa-adherent contrasuppressor cells were shown to be T cells that were I-J + and of the Lyt-1 phenotype. Contrasuppressor T ceils (Tcs) were not present in V. villosa-adherent spleen cell fractions obtained from normal mice, from mice injected with polyvinylpyrrolidonecoupled spleen cells, or from Cy-treated mice injected with S3-SCSM, i.e., mice in which Ts activity is dominant. The V. villosa-adherent cells that abrogated the activity of Ts induced by S3-SCSM in Cy-treated mice did not abrogate suppression mediated by a different subset of S3-specific Ts, suggesting that the Tcs described here do not have activity against all Ts subsets. The ability of S3-SCSM to activate Tcs in normal mice provides an explanation for the inability to detect S3-specific Ts in several previous studies.
